December 2004
Investment Dealers' Digest;12/6/2004, Vol. 70 Issue 47, p50
Trade Publication
This article presents a list of planned new offerings in equity that have been registered with the Securities and Exchange Commission. Delta Petroleum Corp. is located in Denver and it deals in oil and gas exploration. Its security type is common shares. Trinity Industries Inc. is located in Dallas and its business is manufacturing and transportation. Its security type is common shares. Array BioPharma Inc. is located in Boulder and its business is biotechnology. Its security type is common shares. Mendocino Partners is located in Dana Point and its business is acquiring service stations. Its security type is common shares.


Related Articles

  • BioWorld Stock Report For Public Biotechnology Companies.  // BioWorld Insight;2/13/2012, Vol. 20 Issue 7, p17 

    The article lists the stock report for public biotechnology companies including Acadia Pharmaceuticals Inc., AMAG Pharmaceuticals Inc., and ARRAY BioPharma Inc.

  • OTHER NEWS TO NOTE.  // BioWorld Today;4/12/2007, Vol. 18 Issue 71, p2 

    The article presents global news briefs related to biotechnology industries. Array BioPharma Inc. filed a drug application for ARRY-797 and plans to begin a Phase I trial for the drug in cancer patients. Cell Therapeutics Inc. qualified for fast-track designation for the treatment of poor...

  • Other News To Note.  // BioWorld Today;4/8/2011, Vol. 22 Issue 68, p2 

    This section offers news briefs about biotech companies including the filing of a counterclaim by Alnylam Pharmaceuticals Inc. against Tekmira Pharmaceuticals Corp., the announcement of Array BioPharma about the result of its research work with Novartis AG on the development of the...

  • Other News To Note.  // BioWorld Today;7/14/2011, Vol. 22 Issue 135, p2 

    This section offers news briefs related to the biotechnology industry as of July 2011. A license agreement was reached between Array BioPharma Inc. and Asian Pharmaceuticals Pte Ltd. for the development of ARRY-543, the HER2/EGFR inhibitor of Array. Neuronal stem cells were developed by...

  • Array BioPharma anticancer compound cleared to advance into human clinical trials.  // PharmaWatch: Biotechnology;April 2004, Vol. 3 Issue 4, p6 

    Reports that Array BioPharma Inc.'s anticancer compound, ARRAY-142886 has been cleared by the U.S. Food and Drug Administration to advance into human clinical trials. Administration of ARRAY-142886 in certain preclinical skin, pancreatic, colon, lung and breast tumor models resulted in tumor...

  • FINANCINGS ROUNDUP.  // BioWorld Today;12/24/2008, Vol. 19 Issue 249, p4 

    This section offers news briefs related to biotechnology companies in the U.S. Array BioPharma Inc. received its second draw of $40 million from a loan from Deerfield Management. GTC Biotherapeutics Inc. signed an agreement with LFB Biotechnologies for a $15 million financing. MedMira Inc....

  • Other News To Note.  // BioWorld Today;3/7/2012, Vol. 23 Issue 45, p3 

    This section offers news briefs on biopharmaceuticals industry. Colorado-based Array BioPharma Inc. collaborated with Massachusetts-based Foundation Medicine Inc. in the use of genomic sequencing and analytical capabilities to assess molecular alterations in targeting patients likely to respond...

  • Other News To Note.  // BioWorld Today;7/20/2012, Vol. 23 Issue 140, p2 

    This section offers news briefs related to biotechnology industries. Alexza Pharmaceuticals Inc. has submitted to the European Medicines Agency its responses regarding the Adasuve marketing authorization application. Array BioPharma Inc. has achieved an 8.5 million U.S. dollar milestone in its...

  • CLINIC ROUNDUP.  // BioWorld Today;4/9/2009, Vol. 20 Issue 67, p6 

    The article presents news briefs relevant to the biotechnology industry. Alimera Sciences Inc. was allowed by the data safety monitoring board to continue its clinical test for an intravitreal insert for diabetic macular edema. Array BioPharma Inc. started testing its glucokinase activator...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics